Search

Wu Cheng Winston Shen

Supervisory Patent Examiner (ID: 11158, Phone: (571)272-3157 , Office: P/1628 )

Most Active Art Unit
1632
Art Unit(s)
1632, 1628, 1682, 1621, 1634
Total Applications
377
Issued Applications
62
Pending Applications
83
Abandoned Applications
242

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19067561 [patent_doc_number] => 20240101987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 18/351747 [patent_app_country] => US [patent_app_date] => 2023-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351747 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/351747
POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING Jul 12, 2023 Pending
Array ( [id] => 19096288 [patent_doc_number] => 20240115515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/166782 [patent_app_country] => US [patent_app_date] => 2023-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166782 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/166782
LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF Feb 8, 2023 Pending
Array ( [id] => 18628570 [patent_doc_number] => 20230287441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT [patent_app_type] => utility [patent_app_number] => 18/067214 [patent_app_country] => US [patent_app_date] => 2022-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067214 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/067214
PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT Dec 15, 2022 Pending
Array ( [id] => 18359972 [patent_doc_number] => 20230141563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES [patent_app_type] => utility [patent_app_number] => 17/964534 [patent_app_country] => US [patent_app_date] => 2022-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964534 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/964534
METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES Oct 11, 2022 Abandoned
Array ( [id] => 18921534 [patent_doc_number] => 20240024538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION [patent_app_type] => utility [patent_app_number] => 17/907837 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907837 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907837
EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION Jun 16, 2022 Pending
Array ( [id] => 17836379 [patent_doc_number] => 20220273684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/653114 [patent_app_country] => US [patent_app_date] => 2022-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653114
Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof Feb 28, 2022 Pending
Array ( [id] => 19156198 [patent_doc_number] => 20240148905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS [patent_app_type] => utility [patent_app_number] => 18/277858 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42136 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -55 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277858 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277858
METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS Feb 17, 2022 Pending
Array ( [id] => 19049411 [patent_doc_number] => 20240091380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES [patent_app_type] => utility [patent_app_number] => 18/274499 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274499 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/274499
GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES Jan 30, 2022 Pending
Array ( [id] => 19098123 [patent_doc_number] => 20240117351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM [patent_app_type] => utility [patent_app_number] => 18/274826 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274826 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/274826
COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM Jan 27, 2022 Pending
Array ( [id] => 18862317 [patent_doc_number] => 20230416753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/037598 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037598 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/037598
SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF Nov 18, 2021 Pending
Array ( [id] => 18903008 [patent_doc_number] => 20240018493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/251941 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -100 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251941 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251941
KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION Nov 9, 2021 Pending
Array ( [id] => 20193838 [patent_doc_number] => 20250270548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 18/039928 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039928 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039928
COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES Nov 7, 2021 Pending
Array ( [id] => 18895539 [patent_doc_number] => 20240011024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/251636 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13716 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251636 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251636
CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME Nov 3, 2021 Pending
Array ( [id] => 18842636 [patent_doc_number] => 20230405040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 18/035198 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -144 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035198 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035198
METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS Nov 3, 2021 Pending
Array ( [id] => 18282936 [patent_doc_number] => 20230098408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/449140 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/449140
SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME Sep 27, 2021 Abandoned
Array ( [id] => 17444199 [patent_doc_number] => 20220064704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) [patent_app_type] => utility [patent_app_number] => 17/410925 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410925 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/410925
METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) Aug 23, 2021 Abandoned
Array ( [id] => 17370385 [patent_doc_number] => 20220025437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION [patent_app_type] => utility [patent_app_number] => 17/386451 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/386451
NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION Jul 26, 2021 Abandoned
Array ( [id] => 18565730 [patent_doc_number] => 20230256057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => TREATMENT OF IMMUNE DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/015820 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015820 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015820
TREATMENT OF IMMUNE DEPRESSION Jul 12, 2021 Pending
Array ( [id] => 18537810 [patent_doc_number] => 20230242911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR [patent_app_type] => utility [patent_app_number] => 18/004877 [patent_app_country] => US [patent_app_date] => 2021-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004877 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004877
MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR Jul 8, 2021 Pending
Array ( [id] => 19641419 [patent_doc_number] => 20240415939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/002767 [patent_app_country] => US [patent_app_date] => 2021-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002767 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002767
COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF Jun 29, 2021 Pending
Menu